Over the last few decades, an increasing number of human SCN5A gene mutations have been described, and these genetic variations have been reported to be associated with many different types of cardiac disorders, such as Brugada syndrome (36, 37), long QT syndrome (38), and cardiac conduction system dysfunction (39). This evidence concerns the gene SCN5A and Brugada syndrome.